Direct CP, T and/or CPT violations in the K^0-\bar{K^0} system - Implications of the recent KTeV results on 2π2\pi decays -

The recent results on the CP violating parameters Re(e'/e) and \Delta\phi = \phi_{00}-\phi_{+-} reported by the KTeV Collaboration are analyzed with a view to constrain CP, T and CPT violations in a decay process. Combining with some relevant data compiled by the Particle Data Group, we find Re(e_2-e_0) = (0.85 +- 3.11)*10^{-4} and Im(e_2-e_0) = (3.2 +- 0.7)*10^{-4}, where Re(e_I) and Im(e_I) represent respectively CP/CPT and CP/T violations in decay of K^0 and \bar{K^0} into a 2\pi state with isospin I.Comment: 7 pages, No figure

An updated analysis of eps'/eps in the standard model with hadronic matrix elements from the chiral quark model

We discuss the theoretical and experimental status of the CP violating ratio eps'/eps. We revise our 1997 standard-model estimate-based on hadronic matrix elements computed in the chiral quark model up to O(p^4) in the chiral expansion-by including an improved statistical analysis of the uncertainties and updated determination of the Cabibbo-Kobayashi-Maskawa elements and other short-distance parameters. Using normal distributions for the experimental input data we find Re eps'/eps = (2.2 \pm 0.8) x 10^{-3}, whereas a flat scanning gives 0.9 x 10^{-3} < Re eps'/eps < 4.8 x 10^{-3}. Both results are in agreement with the current experimental data. The key element in our estimate is, as before, the fit of the Delta I=1/2 rule, which allows us to absorb most of the theoretical uncertainties in the determination of the model-dependent parameters in the hadronic matrix elements. Our semi-phenomenological approach leads to numerical stability against variations of the renormalization scale and scheme dependence of the short- and long-distance components. The same dynamical mechanism at work in the selection rule also explains the larger value obtained for \ratio with respect to other estimates. A coherent picture of K -> pi pi decays is thus provided.Comment: 15 pages, 11 figures, RevTeX, discussion updated, refs adde

Conscious monitoring and control (reinvestment) in surgical performance under pressure.

Research on intraoperative stressors has focused on external factors without considering individual differences in the ability to cope with stress. One individual difference that is implicated in adverse effects of stress on performance is "reinvestment," the propensity for conscious monitoring and control of movements. The aim of this study was to examine the impact of reinvestment on laparoscopic performance under time pressure

Metaverse-Retail Service Quality: A Future Framework for Retail Service Quality in the 3D Internet

This paper argues that service quality in retailing in 3D Collaborative Virtual Environments (aka Metaverses) is distinct from service quality in the more familiar 2D mainly menu-driven web internet store (e-SQ). The study identifies and conceptualises the determinants of Metaverse Retailing service quality (MR-SQ) through a combination of focus groups and Critical Incident Technique. A set of four overarching determining elements of MR-SQ was revealed including customer service, product dimension, store dimension and 3D platform dimension. These incorporate some of the features found in 2D e-SQ but importantly the study indicated new characteristics, unique to MR-SQ. The CVE context presents opportunities for retailers in enhancing social experience, responsive service and creative co-production opportunities. It is within these gaps that respondents identified in 2D retailing that current CVEs and the future Web 3.0 hold appealing prospects for enhancing and producing creative and co-operative online retailing service quality (MR-SQ). The study provides a framework for guidance for retailers as well as for future research. Summary Statement of Contribution: The paper establishes new understanding of the determinants of Metaverse Retailing-Service Quality (MR-SQ). For virtual worlds in general and for service quality in particular, this study shows new MR-SQ dimensions, overlapping dimensions with different meanings to MR-SQ compares to e-SQ, and similar dimensions in both MR-SQ and e-SQ

The European multicenter trial on the safety and efficacy of guided oblique lumbar interbody fusion (GO-LIF)

Background: Because of the implant-related problems with pedicle screw-based spinal instrumentations, other types of fixation have been tried in spinal arthrodesis. One such technique is the direct trans-pedicular, trans-discal screw fixation, pioneered by Grob for spondylolisthesis. The newly developed GO-LIF procedure expands the scope of the Grob technique in several important ways and adds security by means of robotic-assisted navigation. This is the first clinical trial on the GO-LIF procedure and it will assess safety and efficacy. Methods/Design: Multicentric prospective study with n = 40 patients to undergo single level instrumented spinal arthrodesis of the lumbar or the lumbosacral spine, based on a diagnosis of: painful disc degeneration, painful erosive osteochondrosis, segmental instability, recurrent disc herniation, spinal canal stenosis or foraminal stenosis. The primary target criteria with regards to safety are: The number, severity and cause of intra-and perioperative complications. The number of significant penetrations of the cortical layer of the vertebral body by the implant as recognized on postoperative CT. The primary target parameters with regards to feasibility are: Performance of the procedure according to the preoperative plan. The planned follow-up is 12 months and the following scores will be evaluated as secondary target parameters with regards to clinical improvement: VAS back pain, VAS leg pain, Oswestry Disability Index, short form - 12 health questionnaire and the Swiss spinal stenosis questionnaire for patients with spinal claudication. The secondary parameters with regards to construct stability are visible fusion or lack thereof and signs of implant loosening, implant migration or pseudarthrosis on plain and functional radiographs. Discussion: This trial will for the first time assess the safety and efficacy of guided oblique lumbar interbody fusion. There is no control group, but the results, the outcome and the rate of any complications will be analyzed on the background of the literature on instrumented spinal fusion. Despite its limitations, we expect that this study will serve as the key step in deciding whether a direct comparative trial with another fusion technique is warranted

The Impact of |Delta I|=5/2 Transitions in K-> pi pi Decays

We consider the impact of isospin violation on the analysis of K-> pi pi decays. We scrutinize, in particular, the phenomenological role played by the additional weak amplitude, of |Delta I|=5/2 in character, incurred by the presence of isospin violation. We show that Watson's theorem is appropriate in O(m_d-m_u), so that the inferred pi-pi phase shift at sqrt{s}=m_K determines the strong phase difference between the I=0 and I=2 amplitudes in K-> pi pi decay. We find the magnitude of the |Delta I|=5/2 amplitude thus implied by the empirical branching ratios to be larger than expected from estimates of isospin-violating strong and electromagnetic effects. We effect a new determination of the octet and 27-plet coupling constants with strong-interaction isospin violation and with electromagnetic effects, as computed by Cirigliano, Donoghue, and Golowich, and find that we are unable to resolve the difficulty. Exploring the role of |Delta I|=5/2 transitions in the CP-violating observable epsilon'/epsilon, we determine that the presence of a |Delta I|=5/2 amplitude impacts the empirical determination of omega, the ratio of the real parts of the |Delta I|=3/2 to |Delta I|=1/2 amplitudes, and that it generates a decrease in the estimation of epsilon'/epsilon.Comment: 29 pages, 1 ps fig, refs. added, to appear in Phys. Rev.

Role of cAMP in the promotion of colorectal cancer cell growth by Prostaglandin E2

<p>Abstract</p> <p>Background</p> <p>Prostaglandin E2 (PGE2), a product of the cyclooxygenase (COX) reaction, stimulates the growth of colonic epithelial cells. It is inferred that the abrogation of prostaglandins' growth-promoting effects as a result of COX inhibition underlies the advantageous effects of non-steroidal anti-inflammatory drugs in colorectal carcinoma (CRC). Despite this appreciation, the underlying molecular mechanisms remain obscure since cell culture studies have yielded discrepant results regarding PGE2's mitogenicity.</p> <p>Methods</p> <p>We have employed several alternative approaches to score cell proliferation and apoptosis of 4 CRC cell lines exposed to PGE2 under various conditions. To investigate the role of cAMP in PGE2's functions, activation of the cAMP pathway was assessed at different levels (changes in cAMP levels and PKA activity) in cells subjected to specific manipulations including the use of specific inhibitors or prostanoid receptor-selective agonists/antagonists.</p> <p>Results</p> <p>Our data document that the dose-response curve to PGE2 is 'bell-shaped', with nano molar concentrations of PGE2 being more mitogenic than micro molar doses. Remarkably, mitogenicity inversely correlates with the ability of PGE2 doses to raise cAMP levels. Consistent with a major role for cAMP, cAMP raising agents and pertussis toxin revert the mitogenic response to PGE2. Accordingly, use of prostanoid receptor-selective agonists argues for the involvement of the EP3 receptor and serum deprivation of HT29 CRC cells specifically raises the levels of Gi-coupled EP3 splice variants.</p> <p>Conclusion</p> <p>The present data indicate that the mitogenic action of low PGE2 doses in CRC cells is mediated via Gi-proteins, most likely through the EP3 receptor subtype, and is superimposed by a second, cAMP-dependent anti-proliferative effect at higher PGE2 doses. We discuss how these findings contribute to rationalize conflictive literature data on the proliferative action of PGE2.</p

Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer

<p>Abstract</p> <p>Background</p> <p>Prostaglandin E₂(PGE₂) is the major product of Cyclooxygenase-2 (COX-2) in colorectal cancer (CRC). We aimed to assess PGE₂cell surface receptors (EP 1–4) to examine the mechanisms by which PGE₂regulates tumour progression.</p> <p>Methods</p> <p>Gene expression studies were performed by quantitative RT-PCR. Cell cycle was analysed by flow cytometry with cell proliferation quantified by BrdU incorporation measured by enzyme immunoassay. Immunohistochemistry was employed for expression studies on formalin fixed paraffin embedded tumour tissue.</p> <p>Results</p> <p>EP4 was the most abundant subtype of PGE₂receptor in HT-29 and HCA7 cells (which show COX-2 dependent PGE₂generation) and was consistently the most abundant transcript in human colorectal tumours (n = 8) by qRT-PCR (ANOVA, p = 0.01). G0/G1 cell cycle arrest was observed in HT-29 cells treated with SC-236 5 μM (selective COX-2 inhibitor) for 24 hours (p = 0.02), an effect abrogated by co-incubation with PGE₂(1 μM). G0/G1 arrest was also seen with a specific EP4 receptor antagonist (EP4A, L-161982) (p = 0.01). Treatment of HT-29 cells with either SC-236 or EP4A caused reduction in intracellular cAMP (ANOVA, p = 0.01). Early induction in p21^WAF1/CIP1expression (by qRT-PCR) was seen with EP4A treatment (mean fold increase 4.4, p = 0.04) while other genes remained unchanged. Similar induction in p21^WAF1/CIP1was also seen with PD153025 (1 μM), an EGFR tyrosine kinase inhibitor, suggesting EGFR transactivation by EP4 as a potential mechanism. Additive inhibition of HCA7 proliferation was observed with the combination of SC-236 and neutralising antibody to amphiregulin (AR), a soluble EGFR ligand. Concordance in COX-2 and AR localisation in human colorectal tumours was noted.</p> <p>Conclusion</p> <p>COX-2 regulates cell cycle transition via EP4 receptor and altered p21^WAF1/CIP1expression. EGFR pathways appear important. Specific targeting of the EP4 receptor or downstream targets may offer a safer alternative to COX-2 inhibition in the chemoprevention of CRC.</p

A New Prediction for Direct CP Violation \epsilon'/\epsilon and \Delta I = 1/2 Rule

The low energy dynamics of QCD is investigated with special attention paid to the matching between QCD and chiral perturbation theory(ChPT), and also to some useful algebraic chiral operator relations which survive even when we include chiral loop corrections. It then allows us to evaluate the hadronic matrix elements below the energy scale $\Lambda_{\chi} \simeq 1$ GeV. Based on the new analyzes, we present a consistent prediction for both direct CP-violating parameter $\epsilon'/\epsilon$ and $\Delta I =1/2$ rule in the kaon decays. In the leading $1/N_c$ approximation, the isospin amplitudes $A_0$ and $A_2$ are found to agree well with the data, and the direct CP-violating parameter $\epsilon'/\epsilon$ is predicted to be large, which also confirms our early conclusion. Its numerical value is $\epsilon'/\epsilon = 23.6^{+12.4}_{-7.8}\times 10^{-4}(Im\lambda_t/1.2\times 10^{-4})$ which is no longer sensitive to the strange quark mass due to the matching conditions. Taking into account a simultaneous consistent analysis on the isospin amplitudes $A_0$ and $A_2$, the ratio $\epsilon'/\epsilon$ is in favor of the values $\epsilon'/\epsilon = (20\pm 9)\times 10^{-4}$.Comment: 19 pages, ReVtex, no figures, the corrected version to be published in Phys. Rev. D . A more favorable and consistent prediction for direct CP violation is found: epsilon'(prime) /epsilon = (20 \pm 9) x 10^-4, here the contributions from finite meson masses and new isospin symmetry breaking effects have been included. The uncertainties from QCD (or low energy) scale have been considered. More references are adde

Hypoxia and Prostaglandin E Receptor 4 Signalling Pathways Synergise to Promote Endometrial Adenocarcinoma Cell Proliferation and Tumour Growth

The prostaglandin endoperoxide synthase (PTGS) pathway is a potent driver of tumour development in humans by enhancing the biosynthesis and signalling of prostaglandin (PG) E2. PTGS2 expression and PGE2 biosynthesis is elevated in endometrial adenocarcinoma, however the mechanism whereby PTGS and PGE2 regulate endometrial tumour growth is unknown. Here we investigated (a) the expression profile of the PGE synthase enzymes (PTGES, PTGES-2, PTGES-3) and PGE receptors (PTGER1–4) in endometrial adenocarcinomas compared with normal endometrium and (b) the role of PTGER4 in endometrial tumorigenesis in vivo. We found elevated expression of PTGES2 and PTGER4 and suppression of PTGER1 and PTGER3 in endometrial adenocarcinomas compared with normal endometrium. Using WT Ishikawa endometrial adenocarcinoma cells and Ishikawa cells stably transfected with the full length PTGER4 cDNA (PTGER4 cells) xenografted in the dorsal flanks of nude mice, we show that PTGER4 rapidly and significantly enhances tumour growth rate. Coincident with enhanced PTGER4-mediated tumour growth we found elevated expression of PTGS2 in PTGER4 xenografts compared with WT xenografts. Furthermore we found that the augmented growth rate of the PTGER4 xenografts was not due to enhanced angiogenesis, but regulated by an increased proliferation index and hypoxia. In vitro, we found that PGE2 and hypoxia independently induce expression of PTGER4 indicating two independent pathways regulating prostanoid receptor expression. Finally we have shown that PGE2 and hypoxia synergise to promote cellular proliferation of endometrial adenocarcinoma cells